| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM198711263172201 |
| P698 | PubMed publication ID | 3683469 |
| P2093 | author name string | Commerford PJ | |
| Kirsch RE | |||
| Kruskal JB | |||
| Franks JJ | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1361-1365 | |
| P577 | publication date | 1987-11-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease | |
| P478 | volume | 317 |
| Q33645975 | Admission D-dimer testing for differentiating acute aortic dissection from other causes of acute chest pain |
| Q80577263 | Age related elevation of serum macrophage colony stimulating factor (M-CSF) level |
| Q52480523 | Angioscopic Evaluation of Coronary-Artery Thrombi in Acute Coronary Syndromes |
| Q39612745 | Bimodal presentation of the clinical syndromes of coronary atherosclerosis: a review |
| Q39294419 | Blood rheology associated with cardiovascular risk factors and chronic cardiovascular diseases: results of an epidemiologic cross-sectional study |
| Q34369733 | Cardiac markers and risk stratification: an integrated approach |
| Q42280941 | Changes of blood viscosity in patients treated with 5-fluorouracil--a link to cardiotoxicity? |
| Q37879482 | Chlamydia pneumoniae: inflammation and instability of the atherosclerotic plaque |
| Q42287513 | Clinical cardiotoxicity of 5-fluorouracil |
| Q71993564 | Coagulation Activation in Type 2 Diabetes Mellitus: the Higher Coronary Risk of Female Diabetic Patients |
| Q40795448 | Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects |
| Q28208874 | Coagulation, inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb/IIIa inhibition and low molecular weight heparin |
| Q34770876 | D-Dimer for venous thromboembolism diagnosis: 20 years later |
| Q34376936 | Diagnosis and risk stratification in patients with acute coronary syndromes according to ESC guidelines |
| Q50324333 | Diagnostic Value of D-Dimer in Acute Myocardial Infarction Among Patients With Suspected Acute Coronary Syndrome |
| Q69923214 | Diagnostic value of plasma D-dimer in suspected pulmonary embolism |
| Q28569420 | Dietary oil modifies the plasma proteome during aging in the rat |
| Q71827452 | Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors |
| Q33494171 | Disordered hemostasis in extrahepatic portal hypertension |
| Q33635828 | Early risk stratification of unstable angina/non-Q myocardial infarction: biochemical markers of coronary thrombosis |
| Q41123331 | Effects of exercise test on plasma markers of an activation of coagulation and/or fibrinolysis in patients with symptomatic or silent myocardial ischemia |
| Q67504463 | Elevated fibrin-related and fibrinogen-related antigens in patients with liver disease |
| Q74314747 | Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction |
| Q74267659 | Enhanced coagulation activation in troponin T-positive unstable angina pectoris |
| Q68320666 | Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina |
| Q68473395 | Fibrin and Fibrin-Related Antigens in Coronary Artery Disease |
| Q67875955 | Fibrin and fibrinogen-related antigens in systemic sclerosis (scleroderma) |
| Q68015550 | Fibrin degradation product D-dimer in the diagnosis of pulmonary embolism |
| Q34027246 | Fibrinogen and coronary risk |
| Q46351736 | Hemostasis findings in headache and psychosocial stress associated with cerebral ischemia |
| Q41141603 | Hormone replacement therapy and hemostasis: principles of a complex interaction |
| Q39607042 | Identification and transport of patients with acute myocardial infarction for thrombolytic therapy |
| Q36811963 | Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina |
| Q78115921 | Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects |
| Q73833794 | Infantile obesity: a situation of atherothrombotic risk? |
| Q51719376 | Is routine preoperative hemodynamic evaluation of nonagenarians necessary? |
| Q33636721 | Laboratory diagnosis of venous thromboembolism |
| Q38935475 | Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome. |
| Q36082001 | Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction |
| Q35088065 | Mechanisms of plaque vulnerability and rupture |
| Q34086042 | Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms |
| Q35585929 | Pathophysiology of plaque rupture and the concept of plaque stabilization |
| Q70150299 | Pathophysiology of unstable angina |
| Q73832115 | Percutaneous interventions alter the hemostatic profile of patients with unstable versus stable angina |
| Q52042593 | Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina. |
| Q61669298 | Plasma level changes of fibrinopeptide a after uncomplicated coronary angioplasty |
| Q37906211 | Platelet inhibitor therapy. Agents and clinical implications. |
| Q58829366 | Post-meal coagulation activation in diabetes mellitus: the effect of acarbose |
| Q34369762 | Prognostic role of hemostatic markers in acute coronary syndromes patients |
| Q33614332 | Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome |
| Q47281509 | Rationale for the management of coronary syndromes with low-molecular-weight heparins |
| Q44463743 | The Prognostic Value of Serum Troponin T in Unstable Angina |
| Q35176153 | The Use of Aspirin in Ischemic Heart Disease |
| Q46804489 | The additional value of the CRP test in patients in whom the primary care physician excluded pulmonary embolism |
| Q36331473 | The possible role of hemorheology in atherothrombogenesis |
| Q42751421 | The role of serum D-dimer level in the diagnosis of patients admitted to the emergency department complaining of chest pain |
| Q33617268 | Therapeutic options in treating acute myocardial infarction |
| Q73321590 | Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest |
| Q44317617 | Thrombolytic therapy in refractory unstable angina: the role of Holter monitoring |
| Q47256701 | Thrombotic reactant markers in non-ST segment elevation acute coronary syndromes treated with either enoxaparin (low molecular weight heparin) or unfractionated heparin |
| Q38009281 | Unstable angina pectoris |
| Q38255592 | Unstable angina. Approaching treatment with a rational plan |
| Q39530710 | Unstable angina: current concepts of medical management |
| Q74451978 | [Prognostic value of fibrinogen in patients admitted with suspected unstable angina and non-q-wave myocardial infarction] |
| Q26829973 | 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat |
Search more.